Recursion Pharmaceuticals, Inc. (RXRX)
3.89
+0.19
(+5.14%)
USD |
NASDAQ |
Sep 24, 16:00
3.90
+0.01
(+0.26%)
After-Hours: 07:12
Recursion Pharmaceuticals Gross Profit (Annual) : -46.27M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -46.27M |
| December 31, 2024 | -4.593M |
| December 31, 2023 | -6.512M |
| December 31, 2022 | -8.811M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.074M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Twist Bioscience Corp. | 191.00M |
| Absci Corp. | -8.942M |
| Novavax, Inc. | 1.052B |
| Editas Medicine, Inc. | 35.24M |
| Amgen, Inc. | 26.01B |